--- title: "CN HEALTHY FOOD TECH GROUP CORP. C/WTS 30/09/30 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 7.905 M" type: "news" locale: "en" url: "https://longbridge.com/en/news/266621214.md" published_at: "2025-11-19T21:38:53.000Z" --- # CN HEALTHY FOOD TECH GROUP CORP. C/WTS 30/09/30 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 7.905 M Revenue: As of FY2025 Q3, the actual value is USD 7.905 M. EPS: As of FY2025 Q3, the actual value is USD 0.07. EBIT: As of FY2025 Q3, the actual value is USD 4.453 M. ### Wholesale Distribution Segment - **Revenue**: $7,791,395 for the three months ended September 30, 2025, compared to $3,835,199 for the same period in 2024. - **Cost of Revenue**: $2,337,565 for the three months ended September 30, 2025, compared to $1,343,843 for the same period in 2024. - **Gross Profit**: $5,453,830 for the three months ended September 30, 2025, compared to $2,491,356 for the same period in 2024. - **Operating Income**: $5,118,262 for the three months ended September 30, 2025, compared to $2,248,775 for the same period in 2024. ### Live-stream Sales Segment - **Revenue**: $113,670 for the three months ended September 30, 2025, compared to $456,767 for the same period in 2024. - **Gross Profit**: $113,670 for the three months ended September 30, 2025, compared to $456,767 for the same period in 2024. - **Operating Income**: -$307,536 for the three months ended September 30, 2025, compared to $346,464 for the same period in 2024. ### Corporate - **Operating Loss**: -$226,691 for the three months ended September 30, 2025, compared to -$297,771 for the same period in 2024. ### Consolidated Metrics - **Total Revenue**: $7,905,065 for the three months ended September 30, 2025, compared to $4,291,966 for the same period in 2024. - **Total Cost of Revenue**: $2,337,565 for the three months ended September 30, 2025, compared to $1,343,843 for the same period in 2024. - **Gross Profit**: $5,567,500 for the three months ended September 30, 2025, compared to $2,948,123 for the same period in 2024. - **Operating Income**: $4,584,035 for the three months ended September 30, 2025, compared to $2,297,468 for the same period in 2024. - **Net Income**: $3,344,966 for the three months ended September 30, 2025, compared to $1,567,037 for the same period in 2024. ### Cash Flow - **Operating Cash Flow**: -$5,707,674 for the nine months ended September 30, 2025, compared to $21,852,126 for the same period in 2024. - **Investing Cash Flow**: -$625,392 for the nine months ended September 30, 2025, compared to -$2,807,808 for the same period in 2024. - **Financing Cash Flow**: $1,016,762 for the nine months ended September 30, 2025, compared to $0 for the same period in 2024. ### Future Outlook and Strategy - **Core Business Focus**: The company plans to continue its strategic promotional campaigns and new product launches to drive revenue growth. The focus will be on expanding the customer base and increasing business with existing customers. - **Non-Core Business**: The company is addressing the halted trading of its common stock and warrants on Nasdaq due to the China Securities Regulatory Commission’s review process. The company believes it has satisfied its obligations and is awaiting further information from Nasdaq. ### Related Stocks - [UCFIW.US - CN HEALTHY FOOD TECH GROUP CORP. C/WTS 30/09/30 (TO PUR COM)](https://longbridge.com/en/quote/UCFIW.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Biocon Q3 consol net profit 1.44 bln rupees | Biocon Q3 consol net profit 1.44 bln rupees | [Link](https://longbridge.com/en/news/275805052.md) | | Heijmans FY Underlying EBITDA EUR 252 Mln | Koninklijke Heijmans NV :FY REVENUE INCREASES TO EUR 2.8 BILLION (2024: € 2.6 BILLION).FY UNDERLYING EBITDA OF € 252 MIL | [Link](https://longbridge.com/en/news/275857461.md) | | RIVERVIEW BANCORP INC SEC 10-Q Report | Riverview Bancorp Inc. has released its Form 10-Q report for Q3 FY2025, showing total interest and dividend income of $1 | [Link](https://longbridge.com/en/news/275934222.md) | | Al-Maidan Clinic Q3 Net Profit 1.9 Million Dinars | AL-MAIDAN CLINIC FOR ORAL HEALTH SERVICES :AL-MAIDAN CLINIC Q3 NET PROFIT ATTRIBUTABLE 1.9 MILLION DINARSAL-MAIDAN CLINI | [Link](https://longbridge.com/en/news/275601501.md) | | Sika AG - Sika To Acquire Akkim | Sika AG :SIKA AG - SIKA TO ACQUIRE AKKIMSIKA AG - CLOSING OF ACQUISITION IS EXPECTED IN Q3 OF 2026 | [Link](https://longbridge.com/en/news/275855760.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.